The Growing Challenge of Biofilm & Antimicrobial Resistance

Inquiry

Biofilm formation and microbial contamination are not confined to a single field. They impact healthcare, pharmaceuticals, food production, water systems, industrial manufacturing, and environmental applications worldwide. CD BioSciences provides advanced biofilm models and analytical platforms to support the evaluation of antimicrobial efficacy, mechanism studies, and product development across diverse industries.

Application of Biofilm in Medicine Application of Biofilms in Bionic Technology Application of Biofilm in Bioremediation Application of Biofilm in Chemical Production

CD BioSciences supports medical research by providing biofilm models and standardized testing platforms. Our services enable evaluation of antimicrobial efficacy against biofilm-associated pathogens, including drug-resistant strains and polymicrobial systems. We assist clients in studying infection mechanisms, screening anti-biofilm compounds, and assessing therapeutic strategies using assays such as MBIC, MBEC, and bactericidal testing. These capabilities are widely applied in the development of anti-infective drugs, medical coatings, and treatments targeting chronic and device-associated infections.

Learn More →

CD BioSciences provides biofilm platforms to support the development and evaluation of biomimetic materials and functional surfaces. We establish biofilm to study microbial adhesion, biofilm formation dynamics, and structure–function relationships on engineered substrates. Our services enable quantitative assessment of biofilm–material interactions, including surface colonization, architecture, and stability under defined conditions. Our capabilities support the design and optimization of bio-inspired materials and responsive surfaces with improved performance and durability.

Learn More →

CD BioSciences offers customized biofilm models and analytical services to support environmental and industrial bioremediation studies. We enable evaluation of microbial degradation efficiency, biofilm stability, and pollutant removal performance in systems such as wastewater and contaminated environments. Our platform supports testing under different environmental conditions, helping clients optimize microbial consortia and treatment strategies for improved remediation efficiency.

Learn More →

CD BioSciences provides biofilm platforms to support research and optimization of microbial processes in chemical production. We establish biofilm to evaluate cell adhesion, biofilm development, and metabolic activity within high-density systems. Our services enable quantitative assessment of productivity, stability, and resistance to process stress, as well as comparison with planktonic cultures. These capabilities support the optimization of biofilm reactors, microbial strains, and operating conditions for efficient and scalable production of chemicals, enzymes, and bio-based products.

Learn More →

Pharmaceutical & Drug Development

CD BioSciences supports pharmaceutical and biotechnology R&D by providing advanced biofilm models and standardized testing platforms for evaluating antimicrobial efficacy against biofilm-associated microorganisms. Our services are designed to address the unique challenges of biofilm-mediated resistance and enable robust preclinical assessment of anti-infective candidates.

Model Systems:

We establish biofilm models tailored to different research needs, including:

Single-species biofilm models
Polymicrobial biofilm systems
Drug-resistant strain models

Therapeutic Modalities We Support:

Our platform supports a broad range of antimicrobial agents and therapeutic strategies, including:

Small molecule antimicrobial compounds
Novel antibiotic candidates
Antimicrobial peptides (AMPs)
Natural extracts and phytochemicals

Our capabilities include:

Screening of antimicrobial compounds against planktonic and biofilm-associated cells
Evaluation of anti-biofilm efficacy using MBIC, MBEC, BPC, and BBC assays
Mechanism-of-action studies, including biofilm inhibition and disruption pathways
Testing against drug-resistant strains and polymicrobial biofilms

Oral Care & Dental Applications

CD BioSciences supports oral care product development by providing oral biofilm models and quantitative evaluation platforms for anti-plaque and anti-biofilm performance.

Product Types We Support

Toothpaste
Mouthwash
Oral sprays
Dental gels

Target Microorganisms

Streptococcus mutans
Porphyromonas gingivalis
Candida albicans
......

Testing Services

Anti-biofilm efficacy
Plaque inhibition studies
Contact time optimization
Enamel surface biofilm testing

Key Outcomes

Biofilm biomass reduction
Viable count reduction
Effects of active ingredients
Comparative analysis

Medical Device & Implant Industry

CD BioSciences provides biofilm models to evaluate microbial colonization and antimicrobial performance on medical devices and implant materials.

Product Types We Support

Implant & Prosthetic Models

Orthopedic implants (titanium, alloys)
Dental implants
Cardiovascular implants

Wound & Surface Contact Devices

Wound dressings
Surgical meshes
Contact surfaces exposed to biological fluids

Catheter & Tubing Systems

Urinary catheters
Central venous catheters
Endotracheal tubes

Testing & Analytical Services

Antimicrobial Coating & Surface Evaluation

Anti-adhesion performance testing
Biofilm inhibition and prevention assays
Biofilm eradication studies on coated surfaces
Long-term antimicrobial durability testing
Surface-material interaction analysis

Quantitative Biofilm Assessment

Biofilm biomass quantification (crystal violet)
Viable cell enumeration (CFU)
Live/dead staining analysis
Confocal laser scanning microscopy (CLSM) imaging

Antimicrobial Performance Testing

Biofilm Eradication Concentration (BEC)
Biofilm Inhibitory Concentration (BIC)
Log reduction analysis
Comparison with uncoated control surfaces

Disinfectants & Surface Sanitizers

Products We Support	Hospital disinfectants Surface sanitizers Hand sanitizers & wipes Antimicrobial cleaning agents Air & surface sprays
Active Ingredients	Alcohols Quaternary ammonium compounds (QACs) Chlorine-based disinfectants Hydrogen peroxide / peracetic acid Natural antimicrobial agents

Target Microorganisms	Escherichia coli Staphylococcus aureus Pseudomonas aeruginosa Enterococcus spp. Candida albicans
Testing Services	Antimicrobial activity on surfaces Biofilm removal and reduction Efficacy against mature biofilms Contact time validation Residual activity testing

Case Study: Cleaning Efficacy Study with Detergents

Pseudomonas aeruginosa is an opportunistic pathogen well known for its ability to form robust biofilms on abiotic surfaces. This makes biofilm removal from medical instruments, particularly flexible endoscopes and lumened devices, extremely challenging due to their complex structures. In this project, mono-species biofilms of P. aeruginosa will be established inside PTFE lumens. The study will then evaluate the cleaning efficacy of a new detergent under flow-device assisted manual cleaning conditions, in which a constant flow of detergent solution is applied to assess its ability to remove biofilm contamination.

Project Flowchart

Growing biofilm

Cleaning efficacy testing

Recovery of biofilm materials and assay of analytes

Determination of residual proteins

Determination of residual TOC

Determination of residual colony forming unit of bacterial cells